Tether, the company behind the famous Tether stablecoin, recently made a significant investment after restructuring its business.
Tether’s Strategic Move
On April 29, Tether revealed a big move: investing $200 million into Blackrock Neurotech, a company specializing in neural implant technology. With this investment, Tether now holds the majority stake in Blackrock Neurotech. This investment is part of Tether Evo, a new division of Tether focused on merging human potential with technology.
With this investment, Tether is not only expanding its reach but also contributing to the advancement of technology for the betterment of humanity.
About Blackrock Neurotech
Founded in 2008, Blackrock Neurotech is a global leader in brain-computer-interface (BCI) technology. Their advanced interfaces have helped countless individuals suffering from paralysis and neurological disorders.
Blackrock Neurotech’s technology has empowered patients to control robotic arms, wheelchairs, and even communicate through the power of their thoughts. In a remarkable moment, a patient using their technology fist-bumped U.S. President Barack Obama.
Tether’s Vision
Tether’s $200 million investment aims to bring Blackrock Neurotech’s solutions to more people. This includes funding the commercialization of their technology and advancing research and development efforts. Tether sees this as just the beginning of their journey to support projects that push the boundaries of technology and human potential.
Paolo Ardoino, CEO of Tether, sees Blackrock Neurotech as the start of an exciting journey. He believes in a future where technology enhances our human experience. Blackrock Neurotech’s co-founder, Florian Solzbacher, emphasized the importance of visionary partners in their mission to restore human functions.
